Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0002071426-25-000001
Filing Date
2025-08-11
Accepted
2025-08-11 16:30:28
Documents
1
Effectiveness Date
2025-08-11
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6745
  Complete submission text file 0002071426-25-000001.txt   7957
Mailing Address 16 E 34TH ST, 10TH FL NEW YORK NY 10016
Business Address 16 E 34TH ST, 10TH FL NEW YORK NY 10016 347-703-2534
Formation Bio Drug Development Accelerator Fund LP (Filer) CIK: 0002071426 (see all company filings)

EIN.: 392283142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-554307 | Film No.: 251202464